GRI
GRI Bio Inc

6,750
Mkt Cap
$3.1M
Volume
3.71M
52W High
$11.90
52W Low
$0.19
PE Ratio
-0.01
GRI Fundamentals
Price
$0.2328
Prev Close
$0.2225
Open
$0.223
50D MA
$1.04
Beta
1.41
Avg. Volume
4.32M
EPS (Annual)
-$55.21
P/B
0.38
Rev/Employee
$0.00
Loading...
Loading...
GRI Bio, Inc. is a clinical-stage biopharmaceutical company, which engages in the development and commercialization of therapies for inflammatory, fibrotic, and autoimmune diseases. It focuses on its lead program, GRI-0621, an inhibitor of type 1 invariant Natural Killer T (iNKT) cell activity and is being developed as a novel oral therapeutic for the treatment of idiopathic pulmonary fibrosis. The company was founded by Vipin Kumar Chaturvedi in May 2009 and is headquartered in La Jolla, CA.
Sector:
Health Technology
Industry:
Biotechnology
Employees:
4

Frequently Asked Questions

What is Market Cap of GRI Bio Inc?
What is the 52-week high for GRI Bio Inc?
What is the 52-week low for GRI Bio Inc?
What is GRI Bio Inc stock price today?
What was GRI Bio Inc stock price yesterday?
What is the PE ratio of GRI Bio Inc?
What is the Price-to-Book ratio of GRI Bio Inc?
What is the 50-day moving average of GRI Bio Inc?
How many employess does GRI Bio Inc has?

Latest GRI News

View
Top Discussions

Advertisement|Remove ads.

Advertisement|Remove ads.